In multiple myeloma and head and neck squamous cell carcinoma, p38 inhibitors were successfully used to limit tumor growth and angiogenesis, due indirectly to TTP-mediated inhibition of cytokine secretion [138,139]. Here, ZFP36 is linked to neoplasm.